Nutraceuticals: Regulatory Landscape, Clinical Evidence, Challenges, Nutrivigilance in India

Author:

Lam Alekhya.1,Lukalapu Priyanka1,Kusuma Latha Lidiya1,Chegudi Chegudi1,Vemireddy Madhav.1

Affiliation:

1. Department of Drug Regulatory Affairs, Andhra University College of Pharmaceutical Sciences, Andhra University, 530003, Visakhapatnam, India.

Abstract

Nutraceuticals are the nutrient-dense, physiologically active ingredients that combine the best aspects of diet and medicine to support optimal health and benefits. Nutraceutical product safety, efficacy, and quality requirements are set by regulatory authorities the Central Drugs Standard Control Organization (CDSCO), and the Food Safety and Standards Authority of India (FSSAI). The rapidly expanding nutraceutical market in India is expected to increase, but producing strong clinical data and managing the regulatory environment will be difficult tasks. Clinical evidence supporting health claims for nutraceuticals is still lacking, despite regulatory control, hence thorough clinical trials are required. To guarantee the validity of trial results, issues such as participant compliance, safety concerns, complex study designs, and standardization of dosage must be resolved. Furthermore, the implementation of strong nutrivigilance systems is essential for post-market monitoring and the detection of unfavorable incidents. This review article focuses on the rules, situation, difficulties, safety, and effectiveness aspects of nutraceuticals.

Publisher

A and V Publications

Reference32 articles.

1. Practical challenges faced in conducting clinical trials for Nutraceuticals and current scenario in US and India", International Journal of Science and Engineering Development Research. 2023; 8(7): 539 – 544. Available: http://www.ijrti.org/papers/IJRTI2307079.pdf

2. https://pharmanewsintel.com/features/understanding-the-dangers-of-nutraceuticals-and-dietary-supplements

3. Malve H, Bhalerao P. Past, Present, and Likely Future of Nutraceuticals in India: Evolving Role of Pharmaceutical Physicians. J Pharm Bioallied Sci. 2023;15(2): 68-74. doi: 10.4103/jpbs.jpbs_96_23. Epub 2023 Jun 8. PMID: 37469644; PMCID: PMC10353663.

4. Anand S. An Overview of the Nutraceuticals Industry: Demand, Challenges, Regulations and Clinical Evidence. J Food Science Research. 6(2).

5. https://prorelixresearch.com/portfolio/herbal-and-nutraceutical-clinical-trials/

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3